Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03483610 · ClinicalTrials.gov registry record · NA
Promoting Cervical Cancer Screening for Emergency Department Patients
A NA study of Cervical Cancer, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT03483610: Completed NA study of Cervical Cancer, sponsored by University of Rochester.
NCT03483610 is a NA study of Cervical Cancer that has completed, run by University of Rochester. The registered enrollment target is 95 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03483610, a NA study of Cervical Cancer, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn methods to encourage women to get recommended cervical cancer screening. Cervical cancer screening is an important part of cervical cancer prevention. The study team will determine if the patient is currently up-to-date with cervical cancer screening recommendations. If the patient is not up-to-date, then they will be randomly assigned to one of two interventions. One intervention consists only of referral to a women's health care provider to obtain cervical cancer screening. The other intervention consists of receiving a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening.
Conditions Studied
Interventions
- BEHAVIORAL Text Messaging
- BEHAVIORAL Provider Referral
Study Locations (1)
New York
- University of Rochester, Department of Emergency Medicine - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2019-05-31 |
| Phase | NA |
What the finished NCT03483610 record still lists
NCT03483610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which Text Messaging is the first listed.
NCT03483610 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03483610 about?
NCT03483610 is a clinical study titled "Promoting Cervical Cancer Screening for Emergency Department Patients". The purpose of this study is to learn methods to encourage women to get recommended cervical cancer screening. Cervical cancer screening is an important part of cervical cancer prevention. The study team will determine if the patient is currently up-to-date with cervical cancer screening recommendat...
What is the current status of trial NCT03483610?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2018-06-25. Estimated completion is 2019-05-31.
What conditions does trial NCT03483610 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT03483610?
The interventions under investigation include: Text Messaging (BEHAVIORAL), Provider Referral (BEHAVIORAL).
Who is sponsoring clinical trial NCT03483610?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03483610 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03483610's enrollment target sits among peer trials
95 76th of 144 higher than 69 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI